Integra Lifesciences Holdings (IART) Other Operating Expenses (2009 - 2026)

Integra Lifesciences Holdings' Other Operating Expenses history runs 17 years deep, the most recent figure standing at $178.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 6.88% year-over-year to $178.7 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 71.11% YoY), while the FY2025 annual figure was $1.3 billion, changed N/A from the prior year.
• Other Operating Expenses came in at $178.7 million for Q1 2026 at Integra Lifesciences Holdings, down from $217.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $721.4 million in Q2 2025 to a low of $644000.0 in Q3 2022.
• A 5-year average of $215.6 million and a median of $188.1 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses jumped 380.0% in 2022 and slipped 6.88% in 2026, its largest moves.
• Integra Lifesciences Holdings' Other Operating Expenses stood at $644000.0 in 2022, then soared by 27425.93% to $177.3 million in 2023, then climbed by 11.29% to $197.3 million in 2024, then advanced by 10.41% to $217.8 million in 2025, then retreated by 17.96% to $178.7 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $178.7 million, $217.8 million, and $198.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison